Inflammatory biomarkers in Alzheimer's disease plasma
<p><strong>INTRODUCTION:</strong> Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a "Holy Grail" of AD research and intensively sought; however, there are no well-established plasma markers.</p> <p><strong>METHODS:</st...
Main Authors: | Morgan, A, Touchard, S, Leckey, C, O'Hagan, C, Nevado-Holgado, A, Nima Consortium, Barkhof, F, Bertram, L, Blin, O, Bos, I, Dobricic, V, Engelborghs, S, Frisoni, G, Frölich, L, Gabel, S, Johannsen, P, Kettunen, P, Kłoszewska, I, Legido-Quigley, C, Lleó, A, Martinez-Lage, P, Mecocci, P, Meersmans, K, Molinuevo, J, Peyratout, G, Popp, J, Richardson, J, Sala, I, Scheltens, P, Streffer, J, Soininen, H, Tainta-Cuezva, M, Teunissen, C, Tsolaki, M, Vandenberghe, R, Visser, P, Vos, S, Wahlund, L, Wallin, A, Westwood, S, Zetterberg, H, Lovestone, S, Morgan, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
by: Westwood, S, et al.
Published: (2020) -
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
by: Shi, L, et al.
Published: (2019) -
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Delvenne, A, et al.
Published: (2024) -
MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
by: ten Kate, M, et al.
Published: (2018) -
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
by: Proitsi, P, et al.
Published: (2016)